Public Market Listing
170900KOSPI
Live quotes, historical charts, and market capitalization for Dong-A ST are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(7 total)
7Total Assets
0Approved
3Phase 3 / Filed
4Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | DPP-4 / SGLT2 (combination)Small molecule | Type 2 Diabetes | |
Evogliptin(Suganon) | Phase 3 | DPP-4Small molecule | Type 2 Diabetes |
Udenafil(Zydena) | Phase 3 | PDE5Small molecule | Hypertension |
| Phase 2 | FXRSmall molecule | Type 2 DiabetesMetabolic Dysfunction-Associated Steatohepatitis | |
| Phase 2 | SGLT2Small molecule | Type 2 Diabetes | |
DA-2803 TabNo recent activity | Phase 1 | — | Chronic Hepatitis B |
| Phase 1 | DPP-4 / SGLT2 / AMPK pathway (triple)Small molecule | Type 2 Diabetes |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.